Clinical trial
A Prospective, Post-marketing Study Evaluating Clinical and Radiographic Early Outcomes of Total Knee Arthroplasty With Multigen Plus CCK Alone or Involving the AMF TT Cones.
NCT05314491 is registered in ClinicalTrials.gov with Limacorporate S.p.a as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Post-marketing Study Evaluating Clinical and Radiographic Early Outcomes of Total Knee Arthroplasty With Multigen Plus CCK Alone or Involving the AMF TT Cones.
- Lead sponsor
- Limacorporate S.p.a
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 21, 2022
- Completion date
- July 31, 2026
- Enrollment
- 68 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
revision total knee arthroplasty, total knee arthroplasty